regenerative medicine
Scope
Date
~
-
Korean startups
AI medical startup Arpi wins Pre D.Day X SNU Medicine event
South Korean startup accelerator D.Camp hosted this year’s last demo day on Saturday in collaboration with Seoul National University’s C...
Dec 18, 2022 (Gmt+09:00)
-
Earnings
Celltrion logs strong Q2 earnings powered by biosimilars
South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...
Aug 05, 2022 (Gmt+09:00)
-
Pre-IPOs
Lemon Healthcare aims for IPO and triple jump in revenue
Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...
Jun 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
Latest News
- 1 Samsung's financial arms beat No.1 banking group KB in profit
- 2 Korea’s airlines plagued by elevated fuel costs, strong dollar
- 3 LG Uplus offers Korean Air gift cards to 5G subscribers
- 4 SK Bioscience sells stake in US vaccine developer Novavax
- 5 Naver Cloud takes the lead in Korea’s public AI business